AB= Aberdeen DUN = Dundee ED = Edinburgh GLA = Glasgow. Disease AB DUN ED GLA Service

Size: px
Start display at page:

Download "AB= Aberdeen DUN = Dundee ED = Edinburgh GLA = Glasgow. Disease AB DUN ED GLA Service"

Transcription

1 A current profile of disease and location for testing is provided below. Service: Molecular Genetics Service Summary: Tests by site A current profile of disease and location for testing is provided below. Key: AB= Aberdeen DUN = Dundee ED = Edinburgh GLA = Glasgow Disease Achondroplasia and other skeletal dysplasias Common mutations Acral peeling skin syndrome Sequence analysis of TGM5 Alpha 1 antitrypsin deficiency Z mutation only Alport syndrome COL4A3, COL4A4, COL4A5 NGS sequencing and COL4A5 Aneuploidy screening by QF PCR (prenatal and postnatal) Aneuploidy screening by QF PCR (pregnancy loss) QF-PCR for chromosome. 13,18,21, & Y QF-PCR for chromosome. 13,15, 16, 18,21, 22 & Y Angelman syndrome and UBE3A sequencing Arrhythmogenic right ventricular cardiomyopathy (ARVC) Autosomal recessive congenital ichthyosis (ARCI) Autosomal dominant polycystic kidney disease (ADPKD) Autosomal recessive polycystic kidney disease (ARPKD) PKP2 mutations, DSG2, DSP and DSC2 Sequence analysis of TGM1 ; ALO12B, NIPAL4 and CYP4F22. Sequence analysis of PKD1 and PKD2; Sequence analysis of PKHD1; Bardet Beidl syndrome Variant confirmation Beckwith Wiedemann MS- Biotinidase deficiency Sequence analysis of BTD Birt-Hogg-Dube syndrome FLCN sequencing and Breast/Ovarian Cancer BRCA 1 & 2 sequence/ ; RAD51C&D sequence Page 1 of 7

2 Bullous congenital ichthyosiform erythroderma (BCIE) Sequence analysis of KRT1 and KRT10 s Cadasil NOTCH3 sequencing Capillary malformations Sequence analysis of RASA1 ; Cerebral cavernous malformations (CCM) Sequence three CCM s; CHARGE syndrome CHD7 mutations and Choroideremia Linkage only Clove syndrome Common PIK3CA mutations Cowden Syndrome PTEN sequence/ Congenital hypothyroidism TG, TPO, TSHR sequencing and CPVT RYR2 sequence Crigler-Najjar syndrome Sequence analysis of UGT1A1 Cystic fibrosis (CF) Common mutations Deafness (GJB2, GJB6) Sequence analysis of GJB2 including c.-23+1g>a mutation; testing for GJB6 deletions Dentatorubral-pallidolusian atrophy (DRPLA) Developmental delay Common microdeletions: karrotype and array Di George syndrome (22q11 del) Dilated cardiomyopathy (DCM) 16 panel (see HCM entry) and separate Titin (cardiac isoform) testing by NGS Distal hereditary motor neuropathy Disorders of sexual development (DSD) HSPB1, HSPB3, HSPB8, GARS, BSCL2, TRPV4 sequence AR, SRY, MAMLD1, NR5A1, NR0B1, SRD5A2, HSD17B3 sequencing and Duchenne/ Becker muscular dystrophy (DMD/ BMD) DMD and sequencing Dystonia - torsion Testing for DYT1 deletion. Epidermolysis bullosa simplex (EBS) Epidermolytic palmoplantar keratoderma (EPPK) Sequence analysis of KRT5 and KRT14 Sequence analysis of KRT1 and KRT9 Fabrys disease Sequence analysis of GLA Page 2 of 7

3 Epileptic encephalopathy, early infantile STBP1 sequencing and Factor V Leiden Specific mutation Familial adenomatous polyposis (FAP) Sequence APC and MYH; for deletions Familial hypercholesterolaemia LDLR sequence/ & specific mutations in ApoB/PCSK9 Familial Mediterranean fever Exon 2 & Exon 10 MEFV Female-restricted epilepsy and mental retardation (EFMR) Fibrodysplasia Ossificans Progressiva (FOP) Fragile Mutation test Friedreichs ataxia Mutation test PCHD19 sequencing and ACVR1 P.R206H mutation Gilbert syndrome Common variant in UGT1 promoter Glomulovenous malformations Selected exons of glomulin; common mutations in TIE2 Glut1 deficiency Sequencing and GRA (hyperaldosteronism) Chimaeric fragments Haemochromatosis C282Y and H63D mutations Haemophilia B, Haemophilia A (sickle cell, Beta Thalassaemia, Alpha Thalassaemia) Hereditary neuropathy with liability to pressure palsy (HNPP) Hereditary Hemorrhagic Telangiectasia (HHT) and Primary Pulmonary Hypertension Hereditary motor & sensory neuropathy (HMSN, CMT) Hereditary sensory & autonomic neuropathy HBB sequencing, HBB, HBA PMP22 sequence/ ENG, ACVRL1, SMAD4, GDF2 (BMP9), BMPR2, SMAD9, CAV1, KCNK3 NGS ENG, ACVRL1, BMPR2 PMP22, P0,PMP22,C32, MFN2,LITAF, NEFL, EGR2, DNM2,GDAP1, DNM2, AARS, YARS, HSPB1, HSPB3, HSPB8, GARS, BSCL2, TRPV4, RAB7A, PDK3, PRPS1 sequence SPTLC1 sequence Page 3 of 7

4 Hereditary non-polyposis colorectal cancer (Lynch syndrome) Sequence analysis of MLH1, MSH2 and MSH6 s; Hereditary Spastic Paraplegia SPAST, ATL1 sequencing and Hirschsprung s disease (HSCR) Sequence analysis of RET HNPCC (microsatellite instability testing - MSI) Hypertrophic cardiomyopathy (HCM) Huntington disease Mutation test Microsatellite testing on tumour DNA to detect MSI; testing for common BRAF mutation 16 panel by NGS sequencing including MYBPC3, MYH7, TNNI3, TNNT2 and TPM1. Hypochondroplasia Common mutations Hypokalemic periodic paralysis 1 (HOKPP1) / hyperkalemic periodic paralysis (HYPP) Common mutations in CACN1AS and SCN4A s Ichthyosis bullosa of Siemens Sequence analysis of KRT2 Ichthyosis vulgaris Common FLG mutations Incontinentia pigmenti Common del. & inactivation Juvenile Polyposis syndrome BMPR1A, SMAD4 sequencing and Leber hereditary optic neuropathy (LHON) Common mutations Lesch-Nyhan syndome HPRT mutations Li Fraumeni TP53 sequence/ Lipoprotein lipase deficiency LPL sequence/; APOC2, APOA5, GPI-HBP1, LMF1 sequence Limb Girdle Muscular Dystrophy FKRP and LMNA sequencing and Loeys-Dietz syndrome Sequence analysis TGFBR1, TGFBR2; Long QT syndrome KCNQ1, KCNH2, SCN5A, KCNE1, KCNE2 (and KNCJ2 upon request) Marfan syndrome Sequence analysis of FBN1, TGFBR1 and TGFBR2; MCADD Sequence analysis of ACADM Disease Page 4 of 7

5 Hereditary Malignant Melanoma CDK2NA, CDK4 sequencing Mitochondrial disorders (not LHON) Methyl malonic aciduria (cobalamin deficiency) Sequence analysis for common point mutations. Exons 1-4 MMACHC MODY Sequence analysis of HNF1A, HNF4A, HNF1B and GCK; Multiple endocrine neoplasia type 1 Multiple endocrine neoplasia type 2a/2b and FMTC Sequence analysis of MEN1 Sequence analysis of RET MYH-associated polyposis Common MYH mutations; sequence analysis of MYH Myotonic dystrophy type 1 Mutation test Myotonic dystrophy type 2 Mutation test Nephronophthisis (familial juvenile) Common deletion NPH1 Neurofibromatosis (NF1) Sequence analysis of NF1; Oculopharyngeal muscular dystrophy (OPMD) Ornithine transcarbamylase deficiency (OTC) Screen for OPMD expansion; sequence analysis of 25 codons OTC screen Pachyonychia congenita Testing for mutations in conserved regions of KRT6.16 & 17 Parkinson s disease (early onset) Paroxysmal Kinesigenic Dyskenia Sequence analysis of PARK2 ; screen for common LRRK2 and PINK1 mutations; PRRT2 sequencing Page 5 of 7

6 Pelizaeus Merzbacher Sequence analysis of PLP1 and GJA12: for PLP1 Pendred syndrome-deafness Sequence analysis of SLC26A4 and FOI1 s; for SLC26A4 Peutz Jegher syndrome STK11 sequencing and Preimplantation Genetic Diagnosis (PGD) by preimplantation tic haplotyping (PGH) Phaeochromocytoma/ paraganglioma HFEA licensed conditions offered. If no license is listed referring centre should obtain one before referring family. Sequence analysis of SDHB/SDHC/SDHD, TMEM127 and MA s;. Phenylketonuria (PKU) PAH sequencing and Pontocerebellar hypoplasia 1/2 Sequence EOSC3 and TSEN54 for common mutations Prader Willi syndrome MS- Prothrombin (factor II) g.20210g->a mutation Proximal symphalangism Sequence NOG1; GDF5 RASMAPK testing (including Noonan syndrome, CFC, Leopard syndrome) 13 s within RASMAPK pathway by NGS Rett syndrome MECP2 mutations Russell-Silver syndrome (UPD7) Severe Myoclonic Epilepsy of Infancy (SMEI) Short Stature Homeobox (SHO) MS- and linked markers SCN1A mutations Sequencing and Sickle cell disease HBB Glu7Val sequence only Smith Lemil Opitz DHCR7 sequencing Spinal bulbular muscular strophy (SBMA, Kennedy s) Mutation test Spinal muscular atrophy (SMA) Common mutations, linkage Spinocerebellar ataxia (SCA) SCA1,2,3,6,7 & 8 mutations Stargardt disease Testing ABCA4 by NGS Thrombophilia Testing for p.arg506gln and g.20210g>a mutations Thoracic aortic aneurysms and dissections (TAAD) Additional testing for ACTA2 mutations Trimethylaminuria Exons 2-9 FMO3 Trisomy QFPCR Page 6 of 7

7 Tuberous sclerosis Sequence TSC1 and TSC2; for deletions Disease Type 3 hyperlipidaemia ApoE common variant screen Von Hippel-Lindau (VHL) Sequence VHL; White sponge naevus Sequence KRT4 and KRT13 -inactivation MS restriction digest -linked mental retardation Partial sequence PAK3, confirmation of familial mutations -linked ichthyosis STS sequencing and Y deletion Multiplex PCR to detect deletions; microsatellite markers Page 7 of 7

Informed Consent Columbia Whole Genome or Whole Exome Sequencing

Informed Consent Columbia Whole Genome or Whole Exome Sequencing Informed Consent Columbia Whole Genome or Whole Exome Sequencing Please read the following form carefully and discuss with your ordering physician before signing consent. This consent is intended for the

More information

Whole Exome Sequencing (WES): Questions and Answers for Providers

Whole Exome Sequencing (WES): Questions and Answers for Providers Whole Exome Sequencing (WES): Questions and Answers for Providers 1. What is Whole Exome Sequencing?... 2 2. What is the difference between Whole Exome Sequencing (WES) and Whole Exome Sequencing Plus

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Accredited to ISO 15189:2012 Laboratory Genetics Level 2B, Laboratory Medicine Queen Elizabeth University Hospital Govan Road Glasgow G51

More information

UNIVERSITY OF PENNSYLVANIA GENETIC DIAGNOSTIC LABORATORY

UNIVERSITY OF PENNSYLVANIA GENETIC DIAGNOSTIC LABORATORY GNA FOP Familial Adenomatous Polyposis Beckwith-Wiedemann Syndrome Methylation and high resolution copy number analysis of 11p15.5 with automatic reflex to CDKN1C if negative Methylation analysis of 11p15.5

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK University Hospitals NHS Foundation Trust, Level 1, The Women s Centre John Radcliffe Hospital University Hospitals NHS Foundation Trust OX3

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Building 9 Contact: Dr Catherine Sturgeon BioQuarter Tel: +44 (0)131-2426885 Little France Road Fax: +44 (0)131-242-6882 E-Mail: c.sturgeon@ed.ac.uk Websites: http://edqas.org EH16 4UX Proficiency Testing

More information

UNIVERSITY OF PENNSYLVANIA GENETIC DIAGNOSTIC LABORATORY. Name of Test Turnaround Time Cost CPT codes

UNIVERSITY OF PENNSYLVANIA GENETIC DIAGNOSTIC LABORATORY. Name of Test Turnaround Time Cost CPT codes Beckwith-Wiedemann: methylation and copy number 3-4 weeks $800 81401x2, 81402, 81403 Beckwith-Wiedemann: CDKN1C sequencing 3 weeks $600 81404 Beckwith-Wiedemann: prenatal diagnosis for methylation and

More information

Comprehensive Test Menu August 2018

Comprehensive Test Menu August 2018 Comprehensive Test Menu August 2018 Cancer brain tumors Brain tumors, hereditary BrainTumorNext: 27 genes 14-21 days 8847 Neurofibromatosis type 2 (NF2) NF2 14-21 days 9024 Schwannomatosis SMARCB1 14-21

More information

Comprehensive Test Menu December 2018

Comprehensive Test Menu December 2018 Comprehensive Test Menu December 2018 Cancer brain tumors Brain tumors, hereditary BrainTumorNext: 27 genes 14-21 days 8847 Neurofibromatosis type 2 (NF2) NF2 14-21 days 9024 Schwannomatosis SMARCB1 14-21

More information

LMM / emerge III Network Reference Sequences October 2016 LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene

LMM / emerge III Network Reference Sequences October 2016 LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene ACTA2* Exon 02-09 NM_001613.2 DSG2* Exon 01-15 NM_001943.3 ACTC1* Exon 01-06 NM_005159.4 DSP* Exon 01-24 NM_004415.2 APC* Exon 01-15

More information

DISEASE / DISORDER Price Routine TAT (Calendar Days) Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3

DISEASE / DISORDER Price Routine TAT (Calendar Days) Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3 DISEASE / DISORDER Price Routine TAT (Calendar Days) Achondroplasia + Hypochondroplasia 205 FGFR3 Common mutations in FGFR3 Gene(s) or locus Description of test Category (1138 G>A/C and 1620C>A/G) Adrenal

More information

General Approach to Genetic Testing

General Approach to Genetic Testing Protocol General Approach to Genetic Testing (20491) (Formerly Genetic Testing for Inherited Disorders) Medical Benefit Effective Date: 01/01/14 Next Review Date: 09/14 Preauthorization Yes Review Dates:

More information

DISEASE / DISORDER Price Routine TAT (Calendar Days) Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3

DISEASE / DISORDER Price Routine TAT (Calendar Days) Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3 DISEASE / DISORDER Price Routine TAT (Calendar Days) Achondroplasia + Hypochondroplasia 205 FGFR3 Common mutations in FGFR3 Gene(s) or locus Description of test Category (1138 G>A/C and 1620C>A/G) Adrenal

More information

DISEASE / DISORDER Price Routine TAT (Calendar Days) Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3

DISEASE / DISORDER Price Routine TAT (Calendar Days) Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3 DISEASE / DISORDER Price Routine TAT (Calendar Days) Achondroplasia + Hypochondroplasia 205 FGFR3 Common mutations in FGFR3 Gene(s) or locus Description of test Category (1138 G>A/C and 1620C>A/G) Adrenal

More information

Account # Notes. Physician Name Physician Phone Fax. Diagnosis. CLIA #38D Q11 REQ page 1 of 5

Account # Notes. Physician Name Physician Phone Fax. Diagnosis. CLIA #38D Q11 REQ page 1 of 5 Knight Diagnostic Laboratories Fax: (855) 535-1329 Email: KDLClientServices@ohsu.edu Shipping: 2525 SW 3rd Ave, Ste 350, Portland, OR 97201 Questions? (855) 535-1522 Molecular Genetics Test Requisition

More information

TECHNICAL NOTICE. The CPT coding in this notice is effective January 1, 2013 and replaces the coding currently in use for these assays

TECHNICAL NOTICE. The CPT coding in this notice is effective January 1, 2013 and replaces the coding currently in use for these assays TECHNICAL NOTICE The CPT coding in this notice is effective January 1, 2013 and replaces the coding currently in use for these assays December 2012 The notation (MAAA) indicates "Multianalyte Assay with

More information

Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3 (1138 G>A/C and 1620C>A/G)

Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3 (1138 G>A/C and 1620C>A/G) DISEASE / DISORDER Price Routine TAT (Calendar Days) Gene(s) or locus Description of test (including reference intervals/ clinical decision values where applicable) Category Achondroplasia + Hypochondroplasia

More information

Clinical Cancer Genetics

Clinical Cancer Genetics Clinical Cancer Genetics Lisen Axell, MS, CGC University of Colorado Cancer Center Individuals with cancer Making surgical decisions (lump vs. mast) Making treatment decisions (XRT) Concerns for additional

More information

OXFORD MEDICAL GENETICS LABORATORIES CURRENT DISEASE SERVICES APRIL 2018

OXFORD MEDICAL GENETICS LABORATORIES CURRENT DISEASE SERVICES APRIL 2018 OXFORD MEDICAL GENETICS LABORATORIES CURRENT DISEASE SERVICES APRIL 2018 Please note that there is a 15% surcharge for Non-NHS patients. Highly specialised services (HSS) are indicated. Note: This test

More information

Original Policy Date

Original Policy Date MP 2.04.76 Genetic Counseling Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Created Local Policy/ 12:2013 Return to Medical Policy Index Disclaimer

More information

Code CPT Descriptor Test Purpose and Method Crosswalk Recommendation SEPT9 (Septin9) (e.g., colorectal cancer) methylation analysis

Code CPT Descriptor Test Purpose and Method Crosswalk Recommendation SEPT9 (Septin9) (e.g., colorectal cancer) methylation analysis ASSOCIATION FOR MOLECULAR PATHOLOGY Education. Innovation & Improved Patient Care. Advocacy. 9650 Rockville Pike. Bethesda, Maryland 20814 Tel: 301-634-7939 Fax: 301-634-7995 amp@amp.org www.amp.org August

More information

Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3 (1138 G>A/C and 1620C>A/G)

Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3 (1138 G>A/C and 1620C>A/G) DISEASE / DISORDER Price Routine TAT (Calendar Days) Gene(s) or locus Description of test (including reference intervals/ clinical decision values where applicable) Category Achondroplasia + Hypochondroplasia

More information

SYSTEMATIC ASSESSMENT OF CLINICAL ACTIONABILITY ASSOCIATED WITH GENOMIC VARIATION

SYSTEMATIC ASSESSMENT OF CLINICAL ACTIONABILITY ASSOCIATED WITH GENOMIC VARIATION 1 SYSTEMATIC ASSESSMENT OF CLINICAL ACTIONABILITY ASSOCIATED WITH GENOMIC VARIATION Elizabeth M. Webber, MS Center for Health Research Kaiser Permanente Northwest February 23, 2017 Acknowledgements ClinGen

More information

Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3 (1138 G>A/C and 1620C>A/G)

Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3 (1138 G>A/C and 1620C>A/G) DISEASE / DISORDER Price Routine TAT (Calendar Days) Gene(s) or locus Description of test (including reference intervals/ clinical decision values where applicable) Category Achondroplasia + Hypochondroplasia

More information

CentoCancer STRIVE FOR THE MOST COMPLETE INFORMATION

CentoCancer STRIVE FOR THE MOST COMPLETE INFORMATION CentoCancer STRIVE FOR THE MOST COMPLETE INFORMATION CentoCancer our most comprehensive oncogenetics panel for hereditary mutations Hereditary pathogenic variants confer an increased risk of developing

More information

Genetic Testing for Neurologic Disorders

Genetic Testing for Neurologic Disorders Genetic Testing for Neurologic Disorders MP9497 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes as shown below Pre- and post-test genetic counseling

More information

Neurogenetics Genetic Testing and Ethical Issues

Neurogenetics Genetic Testing and Ethical Issues Neurogenetics Genetic Testing and Ethical Issues Grace Yoon, MD, FRCP(C) Divisions of Neurology and Clinical and Metabolic Genetics The Hospital for Sick Children Objectives 1) To recognize the ethical

More information

Renal Cystic Disease. Dr H Bierman

Renal Cystic Disease. Dr H Bierman Renal Cystic Disease Dr H Bierman Objectives Be able to diagnose renal cystic disease Genetic / non-genetic Be able to describe patterns of various renal cystic disease on routine imaging studies Be able

More information

Genetic Diseases. SCPA202: Basic Pathology

Genetic Diseases. SCPA202: Basic Pathology Genetic Diseases SCPA202: Basic Pathology Amornrat N. Jensen, Ph.D. Department of Pathobiology School of Science, Mahidol University amornrat.nar@mahidol.ac.th Genetic disease An illness caused by abnormalities

More information

General Approach to Genetic Testing

General Approach to Genetic Testing Protocol General Approach to Genetic Testing (20491) Medical Benefit Effective Date: 01/01/17 Next Review Date: 11/18 Preauthorization Yes Review Dates: 01/11, 01/12, 09/12, 05/13, 09/13, 09/14, 09/15,

More information

Information for Service Users

Information for Service Users Molecular Genetics Laboratory Northern Genetics Service Northern Genetics Service Molecular Genetics Laboratory Information for Service Users 2017 Accredited Medical Laboratory Reference No: 2212 Laboratory

More information

panel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders

panel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders NGS tests panel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders UKGTN website lists 13 laboratories offering a total of 56 panel test UKGTN listed panel

More information

Medical Policy Update

Medical Policy Update Medical Policy Update Summer 2017 Highlights of recent medical policy revisions as well as any new medical policies approved by Prevea360 Health Plan s Medical Policy Committee are shown below. The Medical

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK NW Thames Regional Genetics Laboratory Northwick Park Hospital Watford Road Harrow HA1 3UJ United Kingdom Contact: Caroline Sullivan Tel:

More information

PGD: A Celebration of 20 years:

PGD: A Celebration of 20 years: PGD: A Celebration of 20 years: What is Reality and What is Not? Roma June 30, 2010 Mark Hughes, M.D., Ph.D. Professor of Genetics, Internal Medicine, Pathology Director, Genesis Genetics Institute Director,

More information

Colorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital

Colorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital Colorectal Cancer - Working in Partnership David Baty Genetics, Ninewells Hospital Genetics and Pathology National initiatives Colorectal cancer Inherited CRC Sporadic CRC The Liquid Biopsy The future?

More information

Genetic Risk Assessment for Cancer

Genetic Risk Assessment for Cancer Genetic Risk Assessment for Cancer Jennifer Siettmann, MS CGC Certified Genetic Counselor Banner MD Anderson Cancer Center Objectives Describe the role of genetic counseling and genetic testing in patient

More information

CHRONIC MYELOGENOUS LEUKEMIA

CHRONIC MYELOGENOUS LEUKEMIA CHRONIC MYELOGENOUS LEUKEMIA SHUFFLING THE GENETIC DECK IN CML 9 9 (q+) 22 Ph (22q-) bcr bcr-abl abl Fusion protein causes cancer GLEEVEC AND BCR-ABL FUSION PROTEIN GENETIC MEDICINE A. Genetic diseases

More information

Lab Prior Authorization

Lab Prior Authorization Lab Prior Authorization On July 22, 2015, BlueCross BlueShield of South Carolina announced that it will partner with Avalon Healthcare Solutions (Avalon) to administer a comprehensive suite of laboratory

More information

Hereditary Cancer Syndromes

Hereditary Cancer Syndromes Hereditary Cancer Syndromes Nicoleta Voian, MD, MPH Director Clinical Genetics Service Roswell Park Cancer Institute Nicoleta.Voian@Roswellpark.org February 28, 2017 Common Genetics Terms Gene: A hereditary

More information

FRAMBU. Resource Centre for Rare Disorders

FRAMBU. Resource Centre for Rare Disorders FRAMBU Resource Centre for Rare Disorders Frambu Resource Centre for Rare Disorders is one of nine centres working with rare disorders in Norway. All nine centres are part of the Norwegian National Advisory

More information

Developments in Laboratory Genetics

Developments in Laboratory Genetics Developments in Laboratory Genetics Rachel Butler rachel.butler@wales.nhs.uk The Impact of Genomics on Public Health Where are we now? Single gene disorders Core disorders Newborn screening (CF, MCAD)

More information

Genetics & CMT Q&A Questions from the CMTA Genetics & CMT Discussion Forum

Genetics & CMT Q&A Questions from the CMTA Genetics & CMT Discussion Forum Genetics & CMT Q&A Questions from the CMTA Genetics & CMT Discussion Forum Presented by : Shawna Feely, MS, CGC & Carly Siskind MS, LCGC Is CMT a type of Muscular Dystrophy (MD)? Myopathy: a disease of

More information

CHANGE M SEPTEMBER 21, CHAPTER 18 Section 17, pages 9 through 35 Section 17, pages 9 through 37

CHANGE M SEPTEMBER 21, CHAPTER 18 Section 17, pages 9 through 35 Section 17, pages 9 through 37 CHANGE 194 6010.56-M SEPTEMBER 21, 2016 REMOVE PAGE(S) INSERT PAGE(S) CHAPTER 18 Section 17, pages 9 through 35 Section 17, pages 9 through 37 2 GENE(S) TESTED ALK ALK gene testing is covered for the following

More information

Calendar Year (CY) 2017 Clinical Laboratory Fee Schedule (CLFS) Final Determinations

Calendar Year (CY) 2017 Clinical Laboratory Fee Schedule (CLFS) Final Determinations Calendar Year (CY) 2017 Clinical Laboratory Fee Schedule (CLFS) Final Determinations A. Reconsidered Tests For 2016, CMS implemented four new HCPCS G codes for definitive drug testing: G0480 (Drug test(s),

More information

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014 COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014 WENDY MCKINNON, MS, CGC CERTIFIED GENETIC COUNSELOR FAMILIAL CANCER PROGRAM UNIVERSIT Y OF VERMONT MEDICAL CENTER 1 CHARACTERISTICS

More information

MOLECULAR SERVICES. mlabs.umich.edu

MOLECULAR SERVICES. mlabs.umich.edu MOLECULAR SERVICES mlabs.umich.edu 800.862.7284 PICTURED ON LEFT IS MARWAN TAYEH, PH.D, CLINICAL ASSISTANT PROFESSOR, PEDIATRICS - GENETICS, ON RIGHT IS TODD ACKLEY, LABORATORY MANAGER MLabs is a full-service

More information

Genetic testing in Cardiomyopathies

Genetic testing in Cardiomyopathies Genetic testing in Cardiomyopathies Silvia Giuliana Priori Cardiovascular Genetics, Langone Medical Center, New York University School of Medicine, New York, USA and Molecular Cardiology, IRCCS Fondazione

More information

The Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem

The Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem The Israeli population carrier screening program Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem The Israeli population 2015 8,134,500 inhabitants Jews (75.1%) Ashkenazi, non

More information

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions: NutraHacker Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d Instructions: In this report, NutraHacker examines single nucleotide polymorphisms that reveal carrier status

More information

Hereditary Gastric Cancer

Hereditary Gastric Cancer Hereditary Gastric Cancer Dr Bastiaan de Boer Consultant Pathologist Department of Anatomical Pathology PathWest Laboratory Medicine, QE II Medical Centre Clinical Associate Professor School of Pathology

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Genetic Cancer Susceptibility Panels Using Next Generation File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_cancer_susceptibility_panels_using_next_generation_sequencing

More information

Gaucher disease 3/22/2009. Mendelian pedigree patterns. Autosomal-dominant inheritance

Gaucher disease 3/22/2009. Mendelian pedigree patterns. Autosomal-dominant inheritance Mendelian pedigree patterns Autosomal-dominant inheritance Autosomal dominant Autosomal recessive X-linked dominant X-linked recessive Y-linked Examples of AD inheritance Autosomal-recessive inheritance

More information

HEREDITY & CANCER: Breast cancer as a model

HEREDITY & CANCER: Breast cancer as a model HEREDITY & CANCER: Breast cancer as a model Pierre O. Chappuis, MD Divisions of Oncology and Medical Genetics University Hospitals of Geneva, Switzerland Genetics, Cancer and Heredity Cancers are genetic

More information

Genetic Testing for Familial Gastrointestinal Cancer Syndromes. C. Richard Boland, MD La Jolla, CA January 21, 2017

Genetic Testing for Familial Gastrointestinal Cancer Syndromes. C. Richard Boland, MD La Jolla, CA January 21, 2017 Genetic Testing for Familial Gastrointestinal Cancer Syndromes C. Richard Boland, MD La Jolla, CA January 21, 2017 Disclosure Information C. Richard Boland, MD I have no financial relationships to disclose.

More information

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS NF1/SPRED1 and Other RASopathy Related Conditions on Blood/Saliva NF1- only NGS testing and copy number analysis for

More information

The Next Generation of Hereditary Cancer Testing

The Next Generation of Hereditary Cancer Testing The Next Generation of Hereditary Cancer Testing Why Genetic Testing? Cancers can appear to run in families. Often this is due to shared environmental or lifestyle patterns, such as tobacco use. However,

More information

GENETICS IN HEREDITARY NEUROPATHY

GENETICS IN HEREDITARY NEUROPATHY GENETICS IN HEREDITARY NEUROPATHY ERNESTO ALONSO, SWETHA JASTI,MAZEN M.DIMACHKIE, RICHARD J. BAROHN, MELANIE GLENN, OMAR JAWDAT, JEFFREY STATLAND, LAURA HERBELIN, CONSTANTINE FARMAKIDIS,DUAA JABARI, MAMATHA

More information

The Prior Authorization List 2017

The Prior Authorization List 2017 ADVANCING CLINICALLY APPROPRIATE LAB TECHNOLOGY AND SERVICES The Prior Authorization List 2017 Revised April 12, 2017 Visit us at Avalonhcs.com BlueCross BlueShield of South Carolina is an independent

More information

Molecular Genetics Requisition Form 2. Clinical Whole Exome Sequencing Informed Consent 5. Clinical Whole Exome Sequencing Information & FAQ 12

Molecular Genetics Requisition Form 2. Clinical Whole Exome Sequencing Informed Consent 5. Clinical Whole Exome Sequencing Information & FAQ 12 NYGC CLINICAL WHOLE EXOME SEQUENCING Phone: 646-697-7106 Fax: 347-875-4100 Email: Clinical@nygenome.org TABLE OF CONTENTS Molecular Genetics Requisition Form 2 Clinical Whole Exome Sequencing Informed

More information

*Please see amendment for Pennsylvania Medicaid at the end

*Please see amendment for Pennsylvania Medicaid at the end 1 of 202 Number: 0140 Policy *Please see amendment for Pennsylvania Medicaid at the end of this CPB. Aetna considers genetic testing medically necessary to establish a molecular diagnosis of an inheritable

More information

PRE-IMPLANTATION GENETIC DIAGNOSIS AND ASSISTED REPRODUCTIVE TECHNOLOGY IN HAEMOPHILIA DR PENELOPE FOSTER

PRE-IMPLANTATION GENETIC DIAGNOSIS AND ASSISTED REPRODUCTIVE TECHNOLOGY IN HAEMOPHILIA DR PENELOPE FOSTER PRE-IMPLANTATION GENETIC DIAGNOSIS AND ASSISTED REPRODUCTIVE TECHNOLOGY IN HAEMOPHILIA DR PENELOPE FOSTER WHAT IS PGD? early embryo diagnosis allows identification of gender or abnormal gene can select

More information

CANCER GENETICS PROVIDER SURVEY

CANCER GENETICS PROVIDER SURVEY Dear Participant, Previously you agreed to participate in an evaluation of an education program we developed for primary care providers on the topic of cancer genetics. This is an IRB-approved, CDCfunded

More information

Medical Policy Preimplantation Genetic Testing

Medical Policy Preimplantation Genetic Testing Medical Policy Preimplantation Genetic Testing Document Number: 004 Commercial* and Connector/ Qualified Health Plans Authorization required X No notification or authorization Not covered * Not all commercial

More information

Prices listed correspond to institutional rates only; please contact the lab for insurance rates.

Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Genetic Test Neurofibromatosis Type 1 - NF1 and Legius syndrome SPRED1 $1400 (NF1/SPRED1 negative) 81408,

More information

Prices listed correspond to institutional rates only; please contact the lab for insurance rates.

Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Genetic Test Neurofibromatosis Type 1 - NF1 and Legius syndrome SPRED1 $1400 (NF1/SPRED1 negative) 81408,

More information

Formal Genetics of Humans: Modes of Inheritance. Dr. S Hosseini-Asl

Formal Genetics of Humans: Modes of Inheritance. Dr. S Hosseini-Asl Formal Genetics of Humans: Modes of Inheritance Dr. S Hosseini-Asl 1 Autosomal dominant (AD) a: Wild type (Wt) allele A: Mutant allele aa: Normal phenotype Aa: Affected (heterozygous) AA: Affected (homozygous)

More information

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS NF1/SPRED1 and Other RASopathy Related Conditions NF1 only NGS testing and copy number analysis for the NF1 gene (NF1

More information

Family stories: to illustrate inheritance and the impact on families. Dr Claire Turner Consultant clinical geneticist

Family stories: to illustrate inheritance and the impact on families. Dr Claire Turner Consultant clinical geneticist Family stories: to illustrate inheritance and the impact on families Dr Claire Turner Consultant clinical geneticist Overview With respect to inherited cardiac conditions Simple modes of inheritance (Mendelian)

More information

Enabling Personalized

Enabling Personalized Molecular Enabling Personalized Diagnostics Medicine- Targeted Sequencing: NGS-based solutions Silvia Dorn Roel Reinders- Andreas Diplas Friday, 19.06.2015 Company Overview Founded in April 2011 Development

More information

Basic Definitions. Dr. Mohammed Hussein Assi MBChB MSc DCH (UK) MRCPCH

Basic Definitions. Dr. Mohammed Hussein Assi MBChB MSc DCH (UK) MRCPCH Basic Definitions Chromosomes There are two types of chromosomes: autosomes (1-22) and sex chromosomes (X & Y). Humans are composed of two groups of cells: Gametes. Ova and sperm cells, which are haploid,

More information

Molecular and Cellular Biology Unit School of Life Sciences Manipal University Manipal

Molecular and Cellular Biology Unit School of Life Sciences Manipal University Manipal D i a g n o s t i c Te s t s Molecular and Cellular Biology Unit Manipal University Manipal 576 104 Contact Tel: 0820 2922058; 0820 2923501 Email: dbt@manipal.edu Working Hours Monday to Saturday (9:00

More information

Prices listed correspond to institutional rates only; please contact the lab for insurance rates.

Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Genetic Test TAT ** Neurofibromatosis Type 1 - NF1 and Legius syndrome SPRED1 $1400 (NF1/SPRED1 negative)

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK SW Thames Regional Genetics Laboratory, Jenner Wing, SGUL Cranmer Terrace London SW17 0RE Contact: Mr John Short Tel: +44 (0) 208 725 5332 Fax: +44 (0) 208 725 3440 E-Mail: swtrgl@stgeorges.nhs.uk Website:

More information

Hereditary Cardiovascular Conditions. genetic testing for undiagnosed diseases

Hereditary Cardiovascular Conditions. genetic testing for undiagnosed diseases Hereditary Cardiovascular Conditions genetic testing for undiagnosed diseases What is Hypertrophic Cardiomyopathy (HCM)? normal heart heart with hcm Extra or thick heart muscle Typically in the left ventricle

More information

HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007

HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 MIT OpenCourseWare http://ocw.mit.edu HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms.

More information

The Genetics and Prevention of Sudden Cardiac Death

The Genetics and Prevention of Sudden Cardiac Death The Genetics and Prevention of Sudden Cardiac Death Sudden cardiac death (SCD), a serious public health problem Every day, between 1,600 and 2,000 people die worldwide from genetically caused SCD. 1 SCD

More information

Family history of pancreatic cancer

Family history of pancreatic cancer Family history of pancreatic cancer _ This fact sheet is for people who want to find out about the hereditary risk of pancreatic cancer. You can speak to our specialist nurses on our Support Line about

More information

Reproducibility with zebrafish models of human health and disease

Reproducibility with zebrafish models of human health and disease Reproducibility with zebrafish models of human health and disease Monte Westerfield, University of Oregon, Eugene, USA Sponsored by the Office of the Director National Institutes of Health, the National

More information

NGS in Diagnostics: a practical example in hereditary cardiomyopathies

NGS in Diagnostics: a practical example in hereditary cardiomyopathies NGS in Diagnostics: a practical example in hereditary cardiomyopathies Patricia Norambuena University Hospital Motol, Prague. 2 nd Faculty of Medicine, Charles University VEP Course - November 6 th - 8th,

More information

Beyond Mendel s Laws of Inheritance

Beyond Mendel s Laws of Inheritance Beyond Mendel s Laws of Inheritance 2006-2007 Extending Mendelian genetics Mendel worked with a simple system peas are genetically simple most traits are controlled by a single gene each gene has only

More information

Draw a pedigree during the neurological consultation

Draw a pedigree during the neurological consultation 38 PRACTICAL NEUROLOGY HOW TO DO IT Draw a pedigree during the neurological consultation Saif S.M. Razvi* and Ian Bone *Specialist Registrar and Professor of Neurology, Division of Clinical Neurosciences,

More information

No mutations were identified.

No mutations were identified. Hereditary Heart Health Test DOB: May 25, 1977 ID: 123456 Sex: Female Requisition #: 123456 ORDERING PHYSICIAN Dr. Jenny Jones Sample Medical Group 123 Main St. Sample, CA SPECIMEN Type: Saliva Barcode:

More information

Patterns of Single-Gene Inheritance Cont.

Patterns of Single-Gene Inheritance Cont. Genetic Basis of Disease Patterns of Single-Gene Inheritance Cont. Traditional Mechanisms Chromosomal disorders Single-gene gene disorders Polygenic/multifactorial disorders Novel mechanisms Imprinting

More information

Genetic Cancer Susceptibility Panels Using Next Generation Sequencing

Genetic Cancer Susceptibility Panels Using Next Generation Sequencing Genetic Cancer Susceptibility Panels Using Next Generation Sequencing Policy Number: 2.04.93 Last Review: 7/2017 Origination: 7/2013 Next Review: 7/2018 Policy Blue Cross and Blue Shield of Kansas City

More information

Genetics and Genomics: Applications to Developmental Disability

Genetics and Genomics: Applications to Developmental Disability Tuesday, 12:30 2:00, B1 Objective: Genetics and Genomics: Applications to Developmental Disability Helga Toriello 616-234-2712 toriello@msu.edu Identify advances in clinical assessment and management of

More information

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS NF1/SPRED1 and Other RASopathy Related Conditions on Blood/Saliva NF1- only NGS testing and copy number analysis for

More information

Rare Disease Conditions Eligibility Criteria v1.5.1

Rare Disease Conditions Eligibility Criteria v1.5.1 Rare Disease Conditions Criteria v1.5.1 Document Record ID Key Work stream Rare Diseases Programme Director Mark Caulfield Status Final Document Owner Richard Scott Version 1.5.1 Document Author Andrew

More information

Clinical Genetics in Cardiomyopathies

Clinical Genetics in Cardiomyopathies Clinical Genetics in Cardiomyopathies Γεώργιος Κ Ευθυμιάδης Αναπληρωτής Καθηγητής Καρδιολογίας ΑΠΘ No conflict of interest Genetic terms Proband: The first individual diagnosed in a family Mutation: A

More information

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian ANNOUNCER OPEN: Welcome to CME on ReachMD. This segment, entitled Inherited Susceptibility to Cancer: What Do Primary Care Providers

More information

genetic testing PATIENTS.ANSWERS.RESULTS. MARCH 2019

genetic testing PATIENTS.ANSWERS.RESULTS.   MARCH 2019 genetic testing PATIENTS.ANSWERS.RESULTS. www.aruplab.com/genetics MARCH 2019 Information in this brochure is current as of March 2019. All content is subject to change. Please contact ARUP Client Services

More information

Aortopathy Gene Testing by Sanger sequencing

Aortopathy Gene Testing by Sanger sequencing Department of Molecular Genetics Aortopathy Gene Testing by Sanger sequencing Mutation screening for Marfan syndrome and related disorders has grown to include many genes with overlapping phenotypes. We

More information

Disclosures. Genetic testing goes mainstream

Disclosures. Genetic testing goes mainstream Disclosures I am an employee and shareholder of Sonic Healthcare. Sonic Healthcare provides a variety of medical genetic assays. I do not receive any direct or indirect benefits from other companies. Choosing

More information

The following codes are under management for members who have health benefits covered by WellCare, administered by evicore healthcare.

The following codes are under management for members who have health benefits covered by WellCare, administered by evicore healthcare. WellCare The following codes are under management for members who have health benefits covered by WellCare, administered by evicore healthcare. 81162 81163 81164 cancer) gene analysis; full sequence analysis

More information

Management of higher risk of colorectal cancer. Huw Thomas

Management of higher risk of colorectal cancer. Huw Thomas Management of higher risk of colorectal cancer Huw Thomas Colorectal Cancer 41,000 new cases pa in UK 16,000 deaths pa 60% 5 year survival Adenoma-carcinoma sequence (Morson) Survival vs stage (Dukes)

More information

CMS will not implement the new tier codes for Medicare/Medicaid claims for calendar year 2012.

CMS will not implement the new tier codes for Medicare/Medicaid claims for calendar year 2012. January 1, 2012 Re: 2012 AMA CPT Code Changes Dear Valued Client: The American Medical Association (AMA) has made Current Procedural Terminology (CPT) code changes to the 2012 edition of the CPT coding

More information

COMMERCIAL COVERAGE RATIONALE

COMMERCIAL COVERAGE RATIONALE GENETIC TESTING Protocol: GEN008 Effective Date: January 1, 2018 Table of Contents Page COMMERCIAL COVERAGE RATIONALE... 1 MEDICARE COVERAGE RATIONALE... 17 BACKGROUND... 30 CLINICAL EVIDENCE... 30 APPLICABLE

More information

B Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696

B Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696 Index Note: Page numbers of article titles are in boldface type. A Adenomatous polyposis, familial. See Familial adenomatous polyposis. Anal anastomosis, ileal-pouch, proctocolectomy with, in FAP, 591

More information

Genomics and Genetics in Healthcare. By Mary Knutson, RN, MSN

Genomics and Genetics in Healthcare. By Mary Knutson, RN, MSN Genomics and Genetics in Healthcare By Mary Knutson, RN, MSN Clinical Objectives Understand the importance of genomics to provide effective nursing care Integrate genetic knowledge and skills into nursing

More information

Genetic testing all you need to know

Genetic testing all you need to know Genetic testing all you need to know Sue Clark Consultant Colorectal Surgeon, St Mark s Hospital, London, UK. Colorectal cancer Familial 33% Polyposis syndromes

More information